Physician profile
Tracy Hicks
NPI 1033199898
$2,878.75
in general payments reported to CMS, 2019-2025
27 companies · $463 in 2025
The $463 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $697 · 2020: $198 · 2021: $277 · 2022: $505 · 2023: $418 · 2024: $321 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $458.49 | 2019-2022 | |
| Organon LLC | $288.91 | 2021-2025 | Nexplanon, Jada System, Nuvaring |
| Astellas Pharma US INC | $262.49 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $226.67 | 2019-2024 | Aptima, Novasure, Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $205.29 | 2019-2025 | |
| Lupin INC. | $151.69 | 2019-2020 | |
| Myovant Sciences INC. | $131.00 | 2022 | |
| Mayne Pharma Commercial LLC | $119.47 | 2021-2023 | |
| Pfizer INC. | $119.02 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $119.01 | 2025 | Uzedy |
| Pacira Pharmaceuticals Incorporated | $98.07 | 2019 | |
| Exeltis, USA INC. | $87.89 | 2020-2023 | Slynd |
| Inspire Medical Systems, INC. | $81.95 | 2023 | Inspire |
| Therapeuticsmd, INC. | $76.54 | 2019-2021 | |
| Medical Device Business Services, INC. | $67.54 | 2024 | Harmonic |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $59.98 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Merck Sharp & Dohme LLC | $57.93 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $53.91 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $43.29 | 2023 | Myfembree |
| Duchesnay USA Incorporated | $38.69 | 2019 | |
| Minerva Surgical, INC | $26.03 | 2022 | |
| Agile Therapeutics, INC. | $23.37 | 2021 | |
| Allergan, INC. | $22.95 | 2019 | |
| Boston Scientific Corporation | $19.06 | 2023 | Upsylon |
| Lifenet Health | $16.62 | 2025 | Theragenesis Wound Matrix |
| Coopersurgical, INC. | $12.24 | 2020 | |
| Meditrina | $10.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.